The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider the costs or...

Full description

Bibliographic Details
Main Authors: Benjamin O Yarnoff, Thomas J Hoerger, Siobhan A Simpson, Meda E Pavkov, Nilka R Burrows, Sundar S Shrestha, Desmond E Williams, Xiaohui Zhuo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4942058?pdf=render